Your R&D team is your most valuable qualifying asset. Here's how to protect it. 

Canada's SR&ED program just underwent its most significant expansion in over a decade. With expenditure limits doubled and maximum refundable credits now reaching $2.1 million per year for Canadian-controlled private corporations, companies have more non-dilutive capital to invest in innovation than ever before. And yet, for many of the 2,000+ companies Boast has served across North America, the constraint isn't capital; it's people. 

R&D isn't lab coats and line items. It's people with expertise, motivation, and capacity doing hard work to solve hard problems. If your innovation team is burned out, that capital won't deliver the returns you need, and your next SR&ED or R&D tax credit claim will reflect it. 

At Boast, we've been exploring this challenge from multiple angles: in conversation with Dr. Ty McKinney of 8 Bit Cortex on our What the Tech podcast, and in our recent Capital Allocation Masterclass alongside HR and benefits experts. The picture that emerges is consistent: Companies that invest strategically in their people alongside their R&D infrastructure outperform those that don't. 

Here's what the research and the practitioners say. 

The Burnout Tax: What It's Costing Your R&D Program 

Dr. Ty McKinney, founder of 8 Bit Cortex and a neuroscientist specializing in workplace performance, frames the problem in clear business terms. Burnout is a "hidden cost" organizations pay when leadership, operations, and innovation teams aren't working at full capacity. For leadership, it shows up as revenue left on the table. For operations, it manifests as absenteeism and presenteeism. And for R&D teams, it translates into delayed product launches, increased bugs, higher churn, and slower ARR scaling. 

 

Ty shared a direct example from his own company: “In my personal burnout tax as it relates to the organization, I realized I left at minimum $16,000 on the table.” That’s a micro-scale version of what many tech companies are experiencing across their innovation teams, but the numbers scale accordingly. 

The mechanism is neurological. Chronic stress drives up cortisol and other stress hormones that are supposed to spike and then come back down. In sustained burnout, they stay elevated, interfering with sleep, recovery, and cognitive function—particularly in the prefrontal cortex networks that regulate focus, attention to detail, and the ability to filter out distractions. 

Burnout isn’t something you can “white knuckle” your way through. It’s hormone-based. You have to actually take time to rest and allow your brain and body to reset those hormone systems. 

This matters directly for R&D tax credit programs. Qualifying activities under SR&ED and the U.S. federal R&D tax credit (Section 41) both require systematic investigation, technological advancement, and documented iterative work. A burned-out team produces fewer qualifying activities, maintains worse documentation, and misses the kind of experimental approach that substantiates a strong claim. The burnout tax and the credit claim are directly connected. 

Listen to Ty’s full conversation on What the Tech ? 

The Three Roles Every R&D Company Needs Working at Full Capacity 

Ty’s framework draws on a simple insight: every successful tech company relies on three key roles: The Hipster (leadership/vision/revenue), the Hustler (operations/execution), and the Hacker (innovation/technology). You need all three working effectively together. But burnout compromises the integrity of each. 

For SR&ED claimants in particular, the Hustler role is critical. This person ensures deliverables are met and, for SR&ED claimants specifically, that all R&D tasks are accomplished on time. If your operations layer is burned out, documentation lapses. If your R&D team is running on fumes, technology doesn’t advance as quickly as projected, which means a smaller claim next year. As Ty noted of his own team: “Our team had some burnout over the last year and it resulted in our technology not developing nearly as quickly as we were hoping.” 

Investing SR&ED Capital Strategically: The People Allocation Question 

In Boast’s Capital Allocation Masterclass, we explored how the most successful growth companies aren’t defaulting to reinvesting 100% of SR&ED refunds back into R&D. Instead, they’re asking a different question: “Should we allocate this strategically across innovation AND people investment?” 

The three archetypes Boast observes are:  

  • The Reinvestor (100% back into R&D) 
  • The Banker (100% into runway)  
  • and the Strategist (50-60% R&D, 25-35% benefits, 10-20% HR infrastructure).  

The Strategist model consistently produces better talent outcomes, improved retention, and more sustainable competitive advantage. 

As HR consultant Eugene Fung of Eugenie HR explained during the webinar: “The key question isn’t ‘should we reinvest in R&D?’ The key question is: What’s actually limiting our growth? Because if it’s talent retention or hiring velocity, more R&D budget doesn’t solve that problem.” 

Benefits as a burnout management tool 

Katrina Sinclair of Healthwise Benefits draws a sharp distinction between standard and strategic benefits approaches. Standard plans are one-size-fits-all and managed as a cost center. Strategic plans are customized to workforce demographics, flex-based, and measured by retention, satisfaction, and competitive positioning. 

Ty’s own experience illustrates the ROI. After accessing better benefits coverage, he worked with a data-driven naturopathic doctor who identified food sensitivities causing systemic inflammation and cortisol dysregulation disrupting sleep. The strategic insight: “If you don’t have your hormones balanced at an individual level, it’s not only going to compromise your work quality, it’s going to compromise your long-term health quality as well.” 

Healthwise’s framework for quantifying benefits investment focuses on three lenses: cost of turnover (each voluntary departure typically costs 1.5–2x annual salary), competitive positioning against industry benchmarks, and utilization tracking to identify alignment between what’s offered and what teams actually need. 

Psychological Safety and the Queer Burnout Premium 

One dimension of burnout that is underexplored in the innovation economy: The cost of inauthenticity. Ty’s work with the Alberta Queer Chamber of Commerce and QueerTech builds on clear neuroscience: When people can’t show up as their authentic selves at work, they engage in “expressive suppression,” which drives up chronic stress. “If you don’t have a workplace where people feel they can be their authentic selves in a professional setting, you’re by default incurring burnout risk.” 

The same dynamic applies across racialized minorities, Indigenous people, neurodiverse individuals, and anyone with a disability in the workplace. The burnout risk is intersectional, not isolated. 

8 Bit Cortex is responding with a dedicated program launching in June 2026 (Pride Month): A self-paced burnout management program for LGBTQ+ professionals, designed to help them show up at work most effectively and leverage their creative assets. Companies looking to support queer team members (and retain the talent that often drives the most innovative thinking) should follow their work. 

 

Practical Strategies for Building Healthier R&D Teams 

Drawing on both Ty’s neuroscience framework and Boast’s work with 2,000+ companies across Canada and the U.S., here are the levers that matter most: 

  1. Assess your burnout risk before it shows up in your claim.8 Bit Cortex offers Burnout Risk Assessments that help business ownersidentify early warning signs. As one CEO noted after completing one: it was “unequivocally one of the most eye-opening experiences as a business owner.” 
  2. Make the case for benefits investment using the same ROI logic as R&D.If strategic benefits prevent even 2–3 voluntary departures per year, they typically pay for themselves — and eachretained senior engineer or technical lead represents significantly more qualifying R&D work in next year’s claim. 
  3. Watch for the warning signs in your operations layer.Energy shifts, people becoming withdrawn or disengaged, reactive firefighting with no systematic process, and increasing legal exposure from undocumented policies are all signalsit’s time to invest in HR infrastructure. 
  4. Invest in sleep and recovery as a strategic business tool.The last phase of REM sleep is when we process emotions,consolidate memories, and support learning capacity. Disrupted sleep — a primary symptom of burnout — directly reduces the cognitive performance your R&D team needs to do qualifying work. 
  5. Build psychological safety into your team culture explicitly.Cynicism is contagious — if team memberscan’t be their authentic selves, others pick up on it even if unspoken, and the entire team’s performance degrades. Inclusive cultures aren’t just good values; they’re good R&D strategy. 
  6. Treat SR&ED and R&D credits as a recurring people investment, not a windfall.Canada’s 2026 SR&ED enhancements mean CCPCs can now receive up to $2.1 million in refundable credits. For U.S. companies, the One Big Beautiful Bill Act (signed July 4, 2025)and the restoration of immediate R&D expensing under Section 174A are creating similar opportunities. The compounding effect of strategic capital allocation — better retention, faster hiring, more consistent execution, stronger innovation — builds organizational capability year after year. 

 

Resources 

 

FAQ 

Not directly — but it directly affects the volume and quality of qualifying R&D work your team produces. Fewer qualifying activities, weaker documentation, and delayed project timelines all reduce your claim value. Investing in team health is an investment in your next claim.

SR&ED credits are refundable cash — you can deploy them however you choose. The program specifically reimburses eligible R&D expenditures including salary costs, but what you do with the resulting capital is your strategic decision. Many Boast clients are now allocating a portion to benefits and HR infrastructure.

With the 2026 SR&ED enhancements under Bill C-15 (Royal Assent March 26, 2026), CCPCs can now access up to $2.1 million in refundable credits annually, up from $1.05 million under the previous rules. Expenditure limits doubled from $3M to $6M.

Yes. The federal R&D tax credit under Section 41 supports qualifying R&D expenditures, and many states offer additional credits. The One Big Beautiful Bill Act, signed July 4, 2025, and the restoration of immediate expensing under Section 174A have significantly improved the U.S. R&D credit landscape heading into 2026.

About Boast Boast has helped more than 2,000 companies across North America recover more than $900M in R&D tax credits. Our hybrid model — AI-powered platform combined with specialized human expertise — maximizes qualifying activities and provides a 100% audit defense commitment. Talk to an expert ?